8. Environmental Change and Emerging Infections Flashcards
Overview Summary
In this session, we will examine global environmental change and emerging infections, including trends in emerging infectious diseases (EIDs); global factors contributing to emergence of infectious diseases and their impact on global health; actors, institutional initiatives, and potential conflicting interests; and global and local policy challenges, implications, and what remains to be done for global environmental governance.
Overview Aim
The aim of this session is to provide an overview of the science and policy debate related to environmental change and emerging infectious diseases (EIDs).
Overview Learning outcomes
By the end of this session, you should be able to: Explain the health impacts of EIDs on the global community; Assess key global environmental (socioeconomic and ecological) factors contributing to the emergence of infectious diseases; Critically analyse the role of key actors and the significance of conflicts of interests affecting environmental change and emerging infections; and Examine policy challenges posed by emerging infections and outline potential means of addressing these.
Key terms Emerging infectious disease
: A disease that has appeared and affected a population for the first time, or has existed previously but is rapidly spreading, either in terms of the number of people getting infected, or to new geographical areas (WHO, 2014).
Key terms Environmental health
Environmental health addresses all the physical, chemical, and biological factors external to a person, and all the related factors impacting behaviours. It encompasses the assessment and control of those environmental factors that can potentially affect health. It is targeted toward preventing disease and creating health-supportive environments. This definition excludes behaviour not related to environment, as well as behaviour related to the social and cultural environment, and genetics (EHPA, 2022).
Key terms Global environmental change
Global environmental change encompasses changes in the physical and biogeochemical environment, either caused naturally or influenced by human activities such as deforestation, fossil fuel consumption, urbanisation, land reclamation, agricultural intensification, freshwater extraction, fisheries over-exploitation and waste production. These may manifest at the global scale (e.g. increasing atmospheric CO2) or on a local scale but sufficiently widespread as to be a global phenomenon (e.g. soil degradation) (McMichael et al, 2008).
Key terms Sustainable development
Sustainable development is development that meets the needs of the present, without compromising the ability of future generations to meet their own needs (Brundtland, 1987; SDC, 2022).
1 Why are (re)-emerging infectious diseases a threat?
The rise in prevalence of infectious disease since the 1990s has disproven the assumption that concurrent technological advances will prevent infectious diseases posing a threat to humans (Snowden, 2008). Moreover, research published in 2022 in the journal Nature Climate Change suggests that at least 50% of human pathogenic diseases can be exacerbated by effects of anthropogenic climate change (Mora et al, 2022). Diseases once believed to be under control have re-emerged as major global threats to health. The emergence of drug-resistant strains of bacteria, viruses and other parasites pose new challenges in controlling infectious diseases. We have witnessed the emergence of several important infections, including Zika virus, Rotavirus, Ebola virus, human immunodeficiency virus (HIV), H5N1 influenza virus, various coronaviruses, Monkeypox virus and Marburg virus.
1 Why are (re)-emerging infectious diseases a threat?
Emerging and re-emerging infections increase awareness of our global vulnerability and the borderless impact of infectious diseases, underscoring the need for strong health systems and cooperation between states’ health systems. The World Health Organization (WHO) defines an EID as a disease that either has appeared and affected a population for the first time, or has existed previously but is rapidly spreading, either numerically or geographically (WHO, 2014).
1 Why are (re)-emerging infectious diseases a threat?
Infectious diseases have not disappeared, despite the existence of effective prevention and treatment tools for some of them. The WHO Health Statistics report of 2022 describes the disproportionate impact one infectious disease, Covid-19, has had on populations with less access to vaccination programmes and sufficient healthcare than those living in higher-income countries. The report also states that communicable diseases are responsible for almost 50% of all deaths in low-income countries, with these and middle-income countries bearing the impact on health of diseases such as malaria, tuberculosis (TB), HIV and neglected tropical diseases (WHO, 2022a).
1 Why are (re)-emerging infectious diseases a threat?
Infectious diseases, caused by viruses, bacteria, fungi and other parasites, are major causes of death, disability, and disruption for millions of people. Many people, particularly in low-income countries, lack access to essential preventive and treatment interventions. Children are particularly vulnerable to infectious diseases, with 65% of deaths among children under age five in low-income countries caused by preventable infections such as pneumonia, diarrhoea and malaria. Thus, the adverse impact of infectious diseases is most severe among the poorest and most vulnerable populations with lost productivity, missed educational opportunities, and prohibitive healthcare costs directly impacting families and communities. Economic losses due to infectious diseases extend beyond households, as scarce local and national health system infrastructure and resources are engaged in treating largely preventable diseases (Smith et al, 2019). This can also be seen on a global scale, for example the global economic loss due to severe acute respiratory syndrome (SARS) was estimated at US$40 billion (World Bank, 2012).
Activity 1 Read the short Nature Medicine editorial from July 2022 on ‘Sleepwalking into the next pandemic’ from the essential readings list. What is the main message of this editorial? Comment on the statement ‘research funding seems to flow only when high-income countries are heavily affected’. Why do you think this might be? Reply to at least one of your colleagues’ comments on the discussion board.
Feedback: you may have mentioned that this is likely to be because high-income countries fund research programmes, which in turn makes them more likely to fund research that will impact their own populations rather than those of other countries. In addition, this may win voters’ approval in elections, as people see themselves as likely to benefit from research, rather than anonymous recipients in LMIC. You may also have discussed the concept of enlightened self-interest (the idea that trying to further the interests of others ultimately serves your own interests, e.g., paying for research into vaccines means that others will become vaccinated and therefore less likely to infect you with a disease).
2 Emerging infectious diseases
Incidence of all infectious diseases had declined significantly since the advent of routine vaccinations, including the Expanded Programme on Vaccination instituted in 1974 (Greenwood, 2014). In 1990, 1.1 billion disability-adjusted life years (DALYs) were lost to communicable diseases globally, decreasing to 670,000 DALYs in 2016: a 40% reduction (see Roser and Ritchie, 2021, for these and other interesting data). Since 2000, improved sanitation, advances in medical care and access to this care led many to extrapolate that this trend would continue into the future (Baker et al, 2022). However, this decrease in incidence has not occurred globally, with a larger burden of communicable disease in low- and middle-income countries (Coates et al, 2021).
2 Emerging infectious diseases
In reality, infectious disease incidence has increased and decreased throughout human history. We are going through a period of major technological, demographic, social, political and climatic change. Real-world interventions are implemented within a complex system, which cannot be reduced to the simplicity of the laboratory. Outcomes, such as the spread of antibiotic resistance, need to be addressed. Basic public health services, such as clean water, shelter, food and micronutrients, and sanitation are unavailable for many people, particularly those in low-income countries. Environmental degradation has been ignored or actively encouraged to meet economic needs. The environmental impact of the extraction and unsustainable use of natural resources since the industrial revolution in 1850 has been ignored due to the prioritisation of economic gain. This has resulted in significant health impacts from pollution, destruction of habitats and loss of biodiversity, and climate change (see https://www.statista.com/statistics/264699/worldwide-co2-emissions/ for a visual representation of this).
2 Emerging infectious diseases
Looking at Figure 1, we see over thirty incidents of emerging and re-remerging diseases in countries across the globe. EID events have increased significantly since 1970, with a peak incidence in the 1980s related to the HIV epidemic. While this figure was published in 2016, it is helpful in helping us understand the range of EIDs around the world over time and how some of these still affect us. Approximately 60% of EIDs are zoonoses, over 70% of which, including SARS and Ebola - originated in wild animal populations (Jones et al, 2008). More recent examples include Covid-19, monkeypox and Marburg virus disease. These EIDs have a huge global impact on health, in both higher- and lower-income countries. However, although many new diseases have emerged, such as SARS and the 2009 pandemic influenza strain, significant advances have also occurred in EID control, prevention and treatment (Morens & Fauci, 2012). For example, antiretroviral drugs mean that people living with HIV now have life expectancies similar to those of HIV-negative people, although this is not true for all populations (e.g., injecting drug users) (Katz & Maughan-Brown, 2017).
2.1 What are EIDs?
Emerging infectious diseases (EIDs) are a disease that has appeared and affected a population for the first time, or has existed previously but is rapidly spreading, either in terms of the number of people getting infected, or to new geographical areas (WHO, 2014). Therefore, EIDs can be: new pathogens entering human populations (e.g. HIV-1, SARS); novel variants of existing pathogens (e.g. extensively drug-resistant TB [XDR-TB]); newly recognised causes of common diseases (e.g. Helicobacter pylori – stomach ulcers); pathogens that were once common but experienced a long-term decline before increasing again (e.g. TB, malaria); and pathogens considered rare that have recently increased in incidence (e.g. Lyme disease).
2.1 What are EIDs?
Below we provide some examples of these categories of EIDS and their impact on health: New pathogen strains, such as HIV-1 and Ebola, are what people usually think of as EIDs. Both are zoonoses (transferred from vertebrate non-human animals to humans) due to anthropogenic activities which bring humans and animals into close contact, such as trade in wildlife as food or medicine, global travel, and habitat encroachment.
2.1 What are EIDs?
The Ebola Virus epidemic is an example of an emerging infection that spread rapidly in West Africa and potentially threatened populations over the whole continent. This epidemic occurred mainly in Guinea, Liberia, and Sierra Leone, with a death toll of over 11,400 and 21,200 cases by 15 January, 2015. In August 2014, the WHO declared it a Public Health Emergency of International Concern (PHEIC), resulting in a massive global response (see Wilder-Smith and Osman, 2020, for an overview of this, PHEICs will also be discussed later in the session). Travel-associated cases were documented in five additional countries, and the effects were felt over the entire region, including on local economies (Dramé et al, 2021). Although it is not entirely clear how Ebola initially spreads from animals to humans, it is believed to involve direct contact with an infected wild animal or fruit bat. Besides bats, other wild animals sometimes infected with Ebola virus include several monkey species, chimpanzees, gorillas, baboons and duikers (Briand et al, 2014).
2.1 What are EIDs?
Novel variants of existing pathogens include XDR-TB, multidrug resistant falciparum malaria (MDR Plasmodium falciparum), and methicillin-resistant Staphylococcus aureus.
2.1 What are EIDs?
Pathogens increasing in incidence include those that experienced an initial decline (such as MDR and XDR-TB), or those originally considered rare that are now increasingly prevalent (such as Lyme disease). Lyme disease, a vector-borne disease, is caused by Gram-negative spirochetal bacteria from the genus Borrelia, transmitted by the bite of infected Ixodes ticks. Urbanisation and other anthropogenic factors are implicated in its spread to and increased frequency among humans. Human expansion has led to gradual localised deforestation, increasing contact between humans and tick-dense areas, and has reduced natural predators of deer, chipmunks, and other small rodents, which are primary reservoirs for Lyme disease. Increased human-vector contact has also been linked to global temperature increases (Milman, 2022). In addition, the promotion of use of green spaces for exercise also means increased exposure to ticks and therefore potentially to Lyme disease (Medlock & Leach, 2015).
3 The process of emergence
So how do these diseases emerge? The process of emergence can be divided into four stages or levels, as described in the figure below by Woolhouse and colleagues (2012). This has also been discussed in a paper focusing on emergence of pathogenic viruses, much of which also applies to bacterial and other infections that cause communicable diseases (Parvez & Parveen, 2017).
3 The process of emergence Level 1 (exposure)
is influenced by human behaviour and ecology: pathogen prevalence, habitat encroachment, and exposure. Viruses are likely to come from birds or other mammals, and exposure can be by any route: saliva, fomites, oral-faecal or vector borne (e.g., mosquito) etc. This is going to happen more and more frequently as humans encroach on animals’ natural habitat.
3 The process of emergence Level 2 (infection)
is influenced by human susceptibility, for example, viruses overcoming the barriers between species.
3 The process of emergence Level 3 (transmission)
Many viruses require an animal host or reservoir. Viruses can also be transmitted between humans, and therefore can lead to an epidemic or pandemic – there will be some barriers to transmission, but not all transmission will be prevented. Again, as we encroach on the habitat of other animals, we are more likely to become infected by emerging diseases (or those that are re-emerging).
3 The process of emergence Level 4 (epidemic spread)
can be ecological, through population mixing, or evolutionary, through pathogen adaptation. The virus is transmissible between humans and may cause epidemics. As we build cities and come closer to other humans, we are likely to become infected by these viruses, and, in turn, spread them to our neighbours.
3 The process of emergence
Ecological changes particularly affect Levels 1 and 4; environmental changes affect Levels 2, 3 and 4. Environmental factors could include climate change, deforestation, habitat encroachment and destruction, poor sanitation (a result of overcrowding), construction of dwellings, and creation of new types of reservoirs for vectors (e.g., used tyres as habitat for dengue-spreading mosquitoes) (Parvez & Parveen, 2017; Bennett et al, 2019). There are some important differences between existing and emerging pathogens. The majority of these pathogens are zoonotic, vector-borne and bacterial or viral. Excluding drug resistance, most emerging infections are viral zoonoses, associated with mammals or birds and usually with a broad host range (Jones et al, 2008).
3.1 Global factors contributing to the emergence of selected infection Defining environmental change
Environmental change includes changes in the physical and biogeochemical environment, either caused naturally or influenced by anthropogenic activities such as deforestation, fossil fuel consumption, urbanisation, land reclamation, agricultural intensification, freshwater extraction, fisheries over-exploitation and waste production (Mora et al, 2022).
3.1 Global factors contributing to the emergence of selected infection Defining environmental change
Since the 1980s and the emergence of HIV, the origins of most EIDs are related to environmental change. These changes include socioeconomic (such as urbanisation, transport and travel, and extreme poverty) and ecological processes (such as land usage, deforestation, biodiversity loss, habitat encroachment, and climate change). Large-scale changes to the natural environment (including land-use change, climate change, and the deterioration of ecosystem services) are accelerating and interact to generate emerging global public health threats (Myers & Patz, 2009; Baker et al, 2022; Mora et al, 2022). These threats include increasing exposure to infectious disease, water scarcity, food scarcity, natural disasters, and population displacement (Myers & Patz, 2009). A systematic literature review published in 2022 that examined the effects of climatic hazards on communicable disease found that 58% of infectious diseases have at some point been exacerbated by climate change. The authors state that there are over 1000 ‘unique pathways in which climatic hazards, via different transmission types, led to pathogenic diseases’ (Mora et al, 2022). These pathways include floods, drought, fires, heatwaves, storms and increased sea levels (see https://camilo-mora.github.io/Diseases/ for an infographic that shows these pathways in more detail).
3.1 Global factors contributing to the emergence of selected infection The role of environmental change in emerging infections
Many factors have contributed to the re-emergence of epidemic diseases throughout much of the world, but the principal drivers have been complacency and de-emphasis of infectious diseases in public health policy, increased population growth, uncontrolled urbanisation without concomitant attention to water and waste management, increased globalisation of trade, the ease with which modern air transport quickly spread pathogens and their vectors, while climate change,
3.1 Global factors contributing to the emergence of selected infection The role of environmental change in emerging infections
related deforestation, and species migration can alter the environment so it becomes more or less suitable for various pathogens and disease-carrying vectors (Hess et al, 2020; Mora et al, 2022).
3.1 Global factors contributing to the emergence of selected infection The role of environmental change in emerging infections
In the next section, we will look more closely at population growth, urbanisation and habitat loss, and how these global environmental changes impact health.
3.1 Global factors contributing to the emergence of selected infection The role of environmental change in emerging infections
In 2018, over half of the world’s population (55%) lived in urban areas, although there is still substantial variability in the levels of urbanisation across countries (United Nations, 2018). About 80% of people in Latin America and the Caribbean, 50% in Asia and 43% of those in Africa reside in urban areas. Continuing urbanisation and overall population growth are projected to add 2.5 billion people to the urban population by 2050, with nearly 90% of the increase taking place in Asia and Africa. Factors such as housing quality and overcrowding aid the spread of airborne infectious diseases such as TB, pneumonia and influenza. In makeshift and overcrowded spaces, there may be a lack of access to clean water and proper disposal of urine and faeces, allowing the spread of diarrheal diseases.